Eris Lifesciences acquires trademark Zomelis (for Vildagliptin) from Novartis AG for India market EP News Bureau Dec 4, 2019 Zomelis is used in the treatment of type 2 diabetes and comes under a new class of anti-diabetic drugs known as DPP 4 inhibitors
Alembic Pharma gets tentative nod from USFDA for glycemic control drug Press Trust of India Jul 29, 2019 Quoting IQVIA sales data, the company said, Dapagliflozin Tablets, have an estimated market size of USD 1.7 billion for 12 months,…
